Get in touch

Ambrosia Biosciences

World-class chemistry, best in-class therapeutics

Get in touch

press

Ambrosia Biosciences Announces Series A Financing

Overview

Ambrosia Biosciences Inc. is a drug discovery company developing orally delivered, small molecule-based therapies for obesity and other metabolic disorders.

Who we are

Meet the team

Together, we are united in our goal to deliver safe, effective, and affordable small molecule drugs that transform lives globally.

Nick Traggis

President / COO

Patrice Lee, PhD

Head of Pharmacology

John Mayer, PhD

Chief Scientific Officer

Faraz Naqvi, MD

Medical Director

Kyle Lefkoff

Executive Chairman

Nick Traggis

Director

David Snitman

Director

William Marshall, PhD

Director

John Orwin

Director

Jason Haddock

Director

John Mayer, PhD

Scientific Advisory Board Chairman

Richard DiMarchi, PhD

Scientific Advisory Board

Thomas Hughes, PhD

Scientific Advisory Board

Nick Saccomano, PhD

Strategic Advisor

Kieran Chacko, PhD

Strategic Advisor

Our strategic network

Investors

We partner with seasoned biotech investors who share our purpose, leveraging their expertise to drive forward our drug discovery programs.

//01.

BVF Partners

Visit BVF Partners

//02.

Boulder Ventures

Visit Boulder Ventures

Press

Newsroom

Press